Coqui Radio Pharmaceuticals focuses on the development of innovative radiopharmaceuticals for targeted cancer therapies. Their technology leverages advanced radioisotope production and delivery systems, which enable the precise targeting of cancer cells while minimizing damage to surrounding healthy tissues. This approach enhances the efficacy of treatments and aims to improve patient outcomes in oncology. The company emphasizes the importance of their proprietary formulations and methods in creating radiopharmaceuticals that can be tailored to specific types of cancer, thereby addressing unmet medical needs in the field.

In addition to their therapeutic offerings, Coqui Radio Pharmaceuticals is committed to advancing the science of radiopharmaceuticals through rigorous research and development. They utilize cutting-edge imaging technologies to monitor the distribution and effectiveness of their products in real-time, allowing for better treatment planning and patient management. The integration of these technologies not only supports the development of new therapies but also enhances the understanding of cancer biology, paving the way for future innovations in the treatment of malignancies.

United States

Coquí RadioPharmaceuticals is a radiopharmaceuticals company focused on creating a scalable and reliable domestic supply of Mo-99 to provide low-cost diagnostics and treatments to patients.

Coqui Radio Pharmaceuticals

Company Details